Amplify Weight Loss Drug & Treatment ETF XTER:GXI Holdings History
Amplify Weight Loss Drug & Treatment ETF's Gerresheimer AG Holding Summary
As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 916.00 shares of Gerresheimer AG(XTER:GXI), totaling €69,310.00. This investment constitutes 1.84% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Gerresheimer AG(XTER:GXI) stock.
The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 3 purchases of XTER:GXI, at an average price of €81.69, for a total of 916.00 shares. Based on historical transaction data and XTER:GXI's current price of €50.50, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his XTER:GXI holdings is €-28,567.43, reflecting a -38.18% gain to date.
Amplify Weight Loss Drug & Treatment ETF XTER:GXI (€50.50) Holding Chart
Amplify Weight Loss Drug & Treatment ETF XTER:GXI (€50.50) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price €-/Share | ||
| Shares Sold | 0 | Average Price €-/Share | ||
| Current Price €0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
